Literature DB >> 17004110

A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7.

Emma-Leena Alarmo1, Tuula Kuukasjärvi, Ritva Karhu, Anne Kallioniemi.   

Abstract

Bone morphogenetic proteins (BMPs) regulate diverse cellular processes, such as proliferation, differentiation, and apoptosis. The BMPs have been studied in several cancers, but thus far contradictory results have been obtained and, especially in breast cancer, information on BMPs is still limited. We performed a systematic expression survey of BMPs and their receptors in breast cancer. mRNA expression was studied of seven BMP ligands (BMP2-BMP8) and six receptors (ACVR1, BMPR1A, BMPR1B, BMPR2, ACVR2A, and ACVR2B) that specifically mediate BMP signals. Expression levels were determined in 22 breast cancer cell lines, 39 primary breast tumors, normal human mammary epithelial cell line, and normal mammary gland using semiquantitative RT-PCR. The expression frequencies and expression levels of different BMPs varied considerably in breast cancer with BMP4 and BMP7 being most frequently expressed and showing highest expression levels. The BMP specific receptors were more uniformly expressed and indicated that breast cancer is fully capable of transmitting BMP signals. Expression frequencies and levels for both the ligands and the receptors were in good concordance between the breast cancer cell lines and primary tumors. We can conclude that breast cancers possess functional BMP signaling machinery on the cell surface with distinct differences in the expression of various BMP ligands. Our survey focuses the attention particularly toward BMP4 and BMP7 and suggests their importance in breast cancer. Breast cancer cell lines and the data generated here serve as a good resource for further studies on BMP function in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17004110     DOI: 10.1007/s10549-006-9362-1

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  39 in total

1.  Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer.

Authors:  Dan Guo; Jiayi Huang; Jianping Gong
Journal:  Mol Cell Biochem       Date:  2011-12-14       Impact factor: 3.396

2.  Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediators.

Authors:  Philip Owens; Michael W Pickup; Sergey V Novitskiy; Anna Chytil; Agnieszka E Gorska; Mary E Aakre; James West; Harold L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

3.  MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer.

Authors:  Gianpiero Di Leva; Pierluigi Gasparini; Claudia Piovan; Apollinaire Ngankeu; Michela Garofalo; Cristian Taccioli; Marilena V Iorio; Meng Li; Stefano Volinia; Hansjuerg Alder; Tatsuya Nakamura; Gerard Nuovo; Yunlong Liu; Kenneth P Nephew; Carlo M Croce
Journal:  J Natl Cancer Inst       Date:  2010-04-13       Impact factor: 13.506

Review 4.  The Yin and Yang of bone morphogenetic proteins in cancer.

Authors:  Ashok Singh; Rebecca J Morris
Journal:  Cytokine Growth Factor Rev       Date:  2010-08-04       Impact factor: 7.638

5.  SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer.

Authors:  Kathryn A Clausen; Kimberly R Blish; Charles E Birse; Matthew A Triplette; Timothy E Kute; Gregory B Russell; Ralph B D'Agostino; Lance D Miller; Frank M Torti; Suzy V Torti
Journal:  Breast Cancer Res Treat       Date:  2010-11-27       Impact factor: 4.872

Review 6.  Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.

Authors:  Pawina Jiramongkolchai; Philip Owens; Charles C Hong
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

7.  Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and Invasion.

Authors:  Chanèle Cyr-Depauw; Jason J Northey; Sébastien Tabariès; Matthew G Annis; Zhifeng Dong; Sean Cory; Michael Hallett; Jonathan P Rennhack; Eran R Andrechek; Peter M Siegel
Journal:  Mol Cell Biol       Date:  2016-05-02       Impact factor: 4.272

8.  A dose- and time-controllable syngeneic animal model of breast cancer microcalcification.

Authors:  Fangbing Liu; Preeti Misra; Elaine P Lunsford; Joanne T Vannah; Yuxia Liu; Robert E Lenkinski; John V Frangioni
Journal:  Breast Cancer Res Treat       Date:  2009-09-17       Impact factor: 4.872

9.  Differential expression of cancer-related genes by single and permanent exposure to bone morphogenetic protein 2.

Authors:  Susanne Steinert; Torsten C Kroll; Isabel Taubert; Larissa Pusch; Peter Hortschansky; Klaus Höffken; Stefan Wölfl; Joachim H Clement
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-30       Impact factor: 4.553

10.  Diverse bone morphogenetic protein expression profiles and smad pathway activation in different phenotypes of experimental canine mammary tumors.

Authors:  Helena Wensman; Nils-Erik Heldin; Gunnar Pejler; Eva Hellmén
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.